Shandong Weigao Group Medical Polymer Co (HKSE:01066) Total Liabilities : HK$11,327 Mil (As of Jun. 2023)

View and export this data going back to 2004. Start your Free Trial

What is Shandong Weigao Group Medical Polymer Co Total Liabilities?

Shandong Weigao Group Medical Polymer Co's Total Liabilities for the quarter that ended in Jun. 2023 was HK$11,327 Mil.

Shandong Weigao Group Medical Polymer Co's quarterly Total Liabilities declined from Jun. 2022 (HK$12,092.29 Mil) to Dec. 2022 (HK$10,966.20 Mil) but then increased from Dec. 2022 (HK$10,966.20 Mil) to Jun. 2023 (HK$11,327.49 Mil).

Shandong Weigao Group Medical Polymer Co's annual Total Liabilities increased from Dec. 2020 (HK$10,762.58 Mil) to Dec. 2021 (HK$11,670.10 Mil) but then declined from Dec. 2021 (HK$11,670.10 Mil) to Dec. 2022 (HK$10,966.20 Mil).

Shandong Weigao Group Medical Polymer Co Total Liabilities Historical Data

The historical data trend for Shandong Weigao Group Medical Polymer Co's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shandong Weigao Group Medical Polymer Co Total Liabilities Chart

Shandong Weigao Group Medical Polymer Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Liabilities

Get a 7-Day Free Trial

10,416.39

10,762.58

11,670.10

10,966.20

10,585.07

Shandong Weigao Group Medical Polymer Co Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Total Liabilities	Get a 7-Day Free Trial															11,670.10	12,092.29	10,966.20	11,327.49	10,585.07

Shandong Weigao Group Medical Polymer Co Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Shandong Weigao Group Medical Polymer Co's Total Liabilities for the fiscal year that ended in Dec. 2022 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	6706.048	+	(3909.915	+	350.237
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	10,966

Total Liabilities	=	Total Assets (A: Dec. 2022 )	-	Total Equity (A: Dec. 2022 )
	=	37300.884	-	26334.684
	=	10,966

Shandong Weigao Group Medical Polymer Co's Total Liabilities for the quarter that ended in Jun. 2023 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	7222.703	+	(3754.325	+	350.461
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	11,327

Total Liabilities	=	Total Assets (Q: Jun. 2023 )	-	Total Equity (Q: Jun. 2023 )
	=	37118.239	-	25790.75
	=	11,327

Shandong Weigao Group Medical Polymer Co Total Liabilities Related Terms

Thank you for viewing the detailed overview of Shandong Weigao Group Medical Polymer Co's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Shandong Weigao Group Medical Polymer Co (HKSE:01066) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Shandong Weigao Group Medical Polymer Co Ltd (HKSE:01066) » Definitions » Total Liabilities

Comparable Companies

Traded in Other Exchanges

SHWGY:USA SHWGF:USA UK2:Germany

Address

No.1, Weigao Road, Torch Hi-tech Science Park, Shandong Province, Weihai, CHN

Website

https://www.weigaogroup.com

Shandong Weigao Group Medical Polymer Co Ltd functions in the healthcare sector in China. Its business mainly involves the research and development, production, and sale of single-use medical device products. The company's segments include Medical device products, Orthopaedic products, Interventional products, Pharma packaging products, Blood management products, and others. The company's products comprise consumables including infusion sets, syringes, medical needles, blood bags, prefilled syringes, wound management, blood sampling products; orthopedic materials, and blood purification consumables and equipment. The company operates in the People's Republic of China, the United States, Europe, the Middle East, and Africa, Asia, and others.

Shandong Weigao Group Medical Polymer Co (HKSE:01066) Headlines

No Headlines